75 related articles for article (PubMed ID: 37199043)
21. Interferon-Induced Bone Marrow Stromal Antigen 2 (BST2) Is A Functional Tumor-Initiating Cell Marker In Triple-Negative Breast Cancer.
Souto EP; Gong P; Landua JD; Srinivasan RR; Ganesan A; Dobrolecki LE; Purdy SC; Ford HL; Lewis MT
bioRxiv; 2023 Sep; ():. PubMed ID: 37745510
[TBL] [Abstract][Full Text] [Related]
22. Association of computed tomography scan-assessed body composition with immune and PI3K/AKT pathway proteins in distinct breast cancer tumor components.
Cheng TD; Fu DA; Falzarano SM; Zhang R; Datta S; Zhang W; Omilian AR; Aduse-Poku L; Bian J; Irianto J; Asirvatham JR; Campbell-Thompson M
medRxiv; 2024 May; ():. PubMed ID: 38826360
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
[TBL] [Abstract][Full Text] [Related]
24. [Signal transducer and activator of transcription 3 and cancer associated fibroblasts jointly generate chemo-resistance and affect prognosis in epithelial ovarian cancer].
Zhang YN; Li B; Li YQ; Liu SH; Hou HY; Wang KY; Ao M; Song Y
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):368-377. PubMed ID: 37217344
[No Abstract] [Full Text] [Related]
25. Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer.
Wang F; Long J; Li L; Wu ZX; Da TT; Wang XQ; Huang C; Jiang YH; Yao XQ; Ma HQ; Lian ZX; Zhao ZB; Cao J
Sci Adv; 2023 Jun; 9(24):eadf5464. PubMed ID: 37327339
[TBL] [Abstract][Full Text] [Related]
26. Activin A-Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer.
Pich-Bavastro C; Yerly L; Di Domizio J; Tissot-Renaud S; Gilliet M; Kuonen F
Clin Cancer Res; 2023 Sep; 29(17):3498-3513. PubMed ID: 37327314
[TBL] [Abstract][Full Text] [Related]
27. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway.
Wang D; Keyoumu K; Yu R; Wen D; Jiang H; Liu X; Di X; Zhang S
Mol Med; 2024 May; 30(1):61. PubMed ID: 38760717
[TBL] [Abstract][Full Text] [Related]
28. Multiplex Digital Spatial Profiling in Breast Cancer Research: State-of-the-Art Technologies and Applications across the Translational Science Spectrum.
Rossi M; Radisky DC
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730568
[TBL] [Abstract][Full Text] [Related]
29. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer.
Long L; Fei X; Chen L; Yao L; Lei X
Front Oncol; 2024; 14():1381251. PubMed ID: 38699644
[TBL] [Abstract][Full Text] [Related]
30. A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer.
Nederlof I; Horlings HM; Curtis C; Kok M
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467084
[TBL] [Abstract][Full Text] [Related]
31. High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients.
Morrow E; Pennel K; Hatthakarnkul P; Leslie H; Mallon E; Andersen D; Jamieson N; McMillan D; Roseweir A; Edwards J
Cancer Med; 2023 Jun; 12(12):13225-13240. PubMed ID: 37199043
[TBL] [Abstract][Full Text] [Related]
32. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Pennel KAF; Hatthakarnkul P; Wood CS; Lian GY; Al-Badran SSF; Quinn JA; Legrini A; Inthagard J; Alexander PG; van Wyk H; Kurniawan A; Hashmi U; Gillespie MA; Mills M; Ammar A; Hay J; Andersen D; Nixon C; Rebus S; Chang DK; Kelly C; Harkin A; Graham J; Church D; Tomlinson I; Saunders M; Iveson T; Lannagan TRM; Jackstadt R; Maka N; Horgan PG; Roxburgh CSD; Sansom OJ; McMillan DC; Steele CW; Jamieson NB; Park JH; Roseweir AK; Edwards J
J Exp Clin Cancer Res; 2024 Mar; 43(1):64. PubMed ID: 38424636
[TBL] [Abstract][Full Text] [Related]
33. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
[TBL] [Abstract][Full Text] [Related]
34. Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
Shamis SA; Savioli F; Ammar A; Al-Badran SS; Hatthakarnkul P; Leslie H; Mallon EE; Jamieson NB; McMillan DC; Edwards J
Histol Histopathol; 2024 Feb; 39(2):177-200. PubMed ID: 37681672
[TBL] [Abstract][Full Text] [Related]
35. High expression of TLR3 in triple-negative breast cancer predicts better prognosis-data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays.
Fan L; Sui XY; Jin X; Zhang WJ; Zhou P; Shao ZM
BMC Cancer; 2023 Apr; 23(1):298. PubMed ID: 37005579
[TBL] [Abstract][Full Text] [Related]
36. Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
Mumin NH; Drobnitzky N; Patel A; Lourenco LM; Cahill FF; Jiang Y; Kong A; Ryan AJ
BMC Cancer; 2019 Jan; 19(1):102. PubMed ID: 30678647
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
